Edition:
United States

ResMed Inc (RMD.N)

RMD.N on New York Stock Exchange

71.57USD
24 Mar 2017
Change (% chg)

$0.26 (+0.36%)
Prev Close
$71.31
Open
$71.31
Day's High
$71.98
Day's Low
$71.31
Volume
151,608
Avg. Vol
257,543
52-wk High
$73.46
52-wk Low
$55.15

Latest Key Developments (Source: Significant Developments)

Resmed and BMC/3B Medical settle global litigation
Friday, 20 Jan 2017 05:28pm EST 

Resmed Inc : Resmed and BMC/3B Medical settle global litigation . Resmed Inc - Settlement did not include an admission of liability or wrongdoing by any party . Resmed Inc - BMC and 3B will pay royalties to Resmed . Resmed Inc - Resmed makes one-time payment to 3B to resolve Florida litigation . Resmed Inc - BMC and 3B will be permitted to sell their existing products in exchange for royalty payments to Resmed . Five-Year agreement between three companies resolves all pending litigation before U.S. International Trade Commission . Resmed Inc - Resmed will make a one-time settlement payment to 3B to close Florida litigation between two parties .Resmed - Agreement between 3 companies also resolves lawsuits pending in District Court in Florida and California, foreign litigation in China, Germany.  Full Article

ResMed Inc- on Jan. 9, 2017, entered into second amendment to existing credit agreement
Thursday, 12 Jan 2017 04:37pm EST 

ResMed Inc : ResMed Inc- on January 9, 2017, entered into a second amendment to existing credit agreement- sec filing .ResMed Inc says second amendment increases size of ResMed's senior unsecured revolving credit facility from $1.0 billion to $1.3 billion.  Full Article

Fisher & Paykel Healthcare successful in German court proceedings related to Resmed
Thursday, 1 Dec 2016 03:38pm EST 

Fisher & Paykel Healthcare Corporation : FPH successful in german court proceedings . Fisher & paykel healthcare gmbh has resumed sales of F&P simplus, eson and eson 2 masks in germany .district court in Munich overturned both preliminary injunctions previously granted to Resmed, Inc against co's german unit.  Full Article

ResMed says takes Fisher & Paykel to court over patents
Wednesday, 17 Aug 2016 05:10pm EDT 

ResMed Inc : Files patent infringement actions against Fisher & Paykel Healthcare in U.S., German, New Zealand courts, in U.S. International Trade Commission . In New Zealand, ResMed is asking Auckland court to "stop Fisher & Paykel from manufacturing and exporting infringing masks from that country" .German court stops sale of F&P simplus, eson and eson 2 masks.  Full Article

Fisher & Paykel Healthcare Corporation updates on patent infringement proceedings
Monday, 15 Aug 2016 06:01pm EDT 

Fisher & Paykel Healthcare Corporation Ltd : FPH file patent infringement proceedings against ResMed . Fisher & paykel healthcare corporation-is seeking all available remedies, including damages and injunctive relief .  Full Article

Resmed Q4 non-GAAP earnings per share $0.74
Thursday, 28 Jul 2016 04:05pm EDT 

Resmed Inc : Resmed inc says declared a quarterly dividend of $0.33 per share, a 10 percent increase from previous dividend . Resmed inc. Announces results for the fourth quarter of fiscal year 2016 . Q4 non-gaap earnings per share $0.74 . Q4 gaap earnings per share $0.59 . Q4 revenue $518.6 million versus i/b/e/s view $514 million .Q4 earnings per share view $0.74 -- Thomson Reuters I/B/E/S.  Full Article

ResMed says ITC to investigate infringement of its patents
Friday, 13 May 2016 06:27am EDT 

ResMed Inc : International trade commission to investigate chinese manufacturer BMC Medical's infringement of resmed patents .ITC agreed to review alleged infringement of 4 resmed patents by BMC's first and second generation flow generator products, Resmart & Luna.  Full Article

ResMed to acquire Brightree for $800 Million
Monday, 22 Feb 2016 04:06pm EST 

ResMed:Says a definitive agreement to acquire privately held Brightree.This acquisition adds to ResMed's global leadership in connected healthcare solutions.Under terms of the agreement, co will acquire brightree for $800 million in cash, which co will fund primarily with debt.Deal accretive to gross margins and non-gaap diluted earnings per share.Transaction includes an estimated $300 million from an anticipated future tax benefit.Resmed will fund the deal primarily with debt.  Full Article

ResMed completes acquisition of Inova Labs
Thursday, 4 Feb 2016 09:15am EST 

ResMed Inc:Completed the acquisition of Inova Labs Inc., a privately-held medical device company that develops and commercializes innovative oxygen therapy products.  Full Article

ResMed Inc acquires Inova Labs
Monday, 11 Jan 2016 09:00am EST 

ResMed Inc:Acquires Inova Labs.Financial terms of the transaction were not disclosed.  Full Article

More From Around the Web

BRIEF-ResMed reports Q2 earnings per share $0.54

* Announces results for the second quarter of fiscal year 2017